Production (Stage)
Capha Pharmaceuticals Inc.
FPSUF
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.00K | 500.00 | 1.10K | 900.00 | 1.30K |
| Total Receivables | 100.00 | 600.00 | 400.00 | 800.00 | 300.00 |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.10K | 1.00K | 1.40K | 1.70K | 1.70K |
|
|
|||||
| Total Current Assets | 1.10K | 1.00K | 1.40K | 1.70K | 1.70K |
| Net Property, Plant & Equipment | 200.00 | 200.00 | 300.00 | 300.00 | 300.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.30K | 1.30K | 1.70K | 2.00K | 2.00K |
|
|
|||||
| Total Accounts Payable | 11.80K | 8.50K | 5.00K | 6.00K | 13.20K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 389.70K | 389.30K | 400.10K | 386.90K | 366.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.90K | -- | 4.40K | -- | 2.40K |
| Total Other Current Liabilities | 2.90K | -- | 4.40K | -- | 2.40K |
| Total Current Liabilities | 404.40K | 397.80K | 409.50K | 393.00K | 382.30K |
|
|
|||||
| Total Current Liabilities | 404.40K | 397.80K | 409.50K | 393.00K | 382.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 389.70K | 389.30K | 400.10K | 386.90K | 366.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 404.40K | 397.80K | 409.50K | 393.00K | 382.30K |
|
|
|||||
| Common Stock & APIC | 7.97M | 7.96M | 8.48M | 8.37M | 8.46M |
| Retained Earnings | -10.94M | -10.92M | -11.62M | -11.46M | -11.57M |
| Treasury Stock & Other | 2.57M | 2.57M | 2.73M | 2.70M | 2.73M |
| Total Common Equity | -403.10K | -396.50K | -407.80K | -391.00K | -380.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -403.10K | -396.50K | -407.80K | -391.00K | -380.30K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -403.10K | -396.50K | -407.80K | -391.00K | -380.30K |
|
|
|||||